Yaz News | Yaz Side Effects 2013

A Yaz side effect lawsuit was filed in the Superior Court of the State of California, San Francisco, on March 19, 2013.

The plaintiffs include five women who claim to have suffered from DVT (Deep Vein Thrombosis), and other injuries arising from the use of Yaz.

According to court documents, the women contest that Bayer HealthCare Pharmaceuticals – the manufacturer of Yaz, should have known its Yaz birth control product could cause DVT, and that it was a high-risk drug.

Warning from the FDA (Food and Drug Administration):

WARNINGS AND PRECAUTIONS

Thromboembolic Disorders and Other Vascular Problems

Based on presently available information on Yasmin, DRSP-containing COCs may be associated with a higher risk of venous thromboembolism (VTE) than COCs containing the progestin levonorgestrel or some other progestins…

Women taking or who have taken birth control pills that contain Drospirenone have a sevenfold risk of developing blood clots compared to women who take birth control pills that contain levonorgestrel (a synthetic progestogen).

On April 11 2012, the FDA ordered Bayer to provide stronger and more clear warnings on their packaging labels of Yaz and Yasmin blood-clot dangers.

Today, there are more than 13,000 pending Yaz lawsuits, yet Yaz, Yasmin and Ocella remain some of Bayer’s highest-selling pharmaceuticals.

Anyone affected by pulmonary embolism, blood clots, DVT or stroke after taking Yaz, Yasmin, BeYaz, or Ocella should contact a Multi-district Litigation Lawyer (MDL) who handles Yaz cases.

To contact a MDL attorney that represents women who have been harmed by Yaz, Yasmin, BeYaz or Ocella either fill out the form to your right, or visit our site at The Maher Law Firm

Yaz, Yasmin, Ocella Multidistrict Litigation Attorneys

Steve Maher is a MDL (Multi-district Litigation) attorney representing  women who have been harmed by Yaz, Yasmin and Ocella.

Yaz, Yasmin and Ocella are dangerous drugs that can potentially harm you and your loved ones.

Yaz and Yasmin contain estrogen (in the form of ethinyl estradiol) and Progestin (in the form of the synthetic hormone drospirenone)

The FDA has concluded that birth control pills containing Drospirenone have a 74% increased risk  for blood clots or venous thromboembolism.

Yaz and Yasmin have been known to cause heart attacks, strokes and deep vein thrombosis.  Yaz and Yasmin have been linked to 50 deaths in women as young as 17 and hundreds of injuries.

Bayer AG, based in Leverkusen, Germany manufactures Yaz, Yasmin and Ocella and has to date settled Yaz Lawsuits totaling over $402 million.

The company, originally put aside a total of $246 million U.S. dollars in 2010 and 2011, according to securities filings, and has now more than doubled it’s reserve for Yaz and Yasmin cases to $610.5 million U.S. dollars.

If you or a loved one has been harmed by this dangerous drug, Steve Maher can help.  Steve does not represent drug manufacturers or insurance companies, Steve represents you and your loved ones.

For a FREE no obligation case evaluation, contact The Maher Law Firm today at 1-888-884-1507

 

Yaz Update: Bayer May Have Illegally Marketed Birth Control Pills

According to an online news article posted to Bloomberg’s website this week, it seems that pharmaceutical giant, Bayer AG, could have misled women regarding the potential health risks associated with use of their newer generation of birth control pills. Moreover, based on information collected from the review of internal company e-mails, Bayer may have even sought to market the Yasmin family of oral contraceptives for uses not previously approved by the FDA.

Internal documents provided to lawyers representing women suing Bayer revealed that unit officials within the company discussed promoting the birth control pill, Yaz (a spinoff of Yasmin), as a treatment for all types of premenstrual syndrome (PMS). However, to date, federal regulators have only approved Yaz as a treatment for the most severe form of PMS.

Within the documents, an e-mail message was uncovered which cited an article in Woman’s Day magazine about Yaz. The message, which read, “This article is a nice way of using YAZ for PMS treatment instead of just focusing on the specific class of women battling premenstrual dysphoric disorder, the most severe form of PMS,” was included in a mountain of internal files produced as evidence in ongoing litigation against Bayer.

At the moment, Bayer faces more than 10,000 lawsuits over injuries associated with use of their birth control pills, which allegedly caused women to suffer from blood clots, heart attacks and strokes. The U.S. Food and Drug Administration has even reported that approximately 50 deaths can be tied to Bayer’s pills between the years 2004 and 2008.

The overall safety regarding the Yasmin family of birth control pills continues to be the subject of heated, worldwide debate. Additionally, after reviewing the results collected from extensive research on the pills, the FDA released a statement last month warning that women taking these newer generation oral contraceptives are 74 percent more likely to suffer blood clots then women taking older generation pills.

In January, Bayer is set to face the first of what could be several trials of lawsuits in which Yasmin and Yaz are alleged to have caused serious injury. Many people hold the opinion that the Bayer and its business units have routinely sacrificed the safety and health of women who use their birth control pills, simply to increase the company’s bottom line profits. More than 12 million women in the U.S. and more than 100 million women worldwide use oral contraceptives, and as such, determining the overall safety and efficacy of these products is of the utmost importance.

Yaz Side Effects Called “Multiple Rare Events” by Bayer

In a New York Times article on Yaz and its dangerous side effects, Dr. Grimes a paid consultant for Bayer was quoted as saying “a multiple of a rare event is still a rare event.”

This could be true, if we were talking about two headed snakes, or volcanoes. But when thinking of women’s healthcare and prescriptions, does it apply?

By this logic, women developing life threatening blood clots after taking Yaz is rare. The fact that it happens to many women all over the US and the world, is just “multiple” rare events. It begs the question, how many life threatening and fatal “rare events” need to occur before it becomes a common event?